baber/WOPTO huggingface dataset:
Patent IL-80002-A0 (IL)
Title: Metal working using lubricants containing basic alkaline earth metal salts
IPC: C10N40/24
Filed: 1986-09-10
Abstract: Lubricants useful in metal working processes, especially cutting, comprise (A) a lubricating oil and (B) a basic alkaline earth metal salt or borated complex thereof. Component B is preferably a basic calcium sulfonate prepared by a specific method. The lubricants may also contain at least one of (C) a specific active sulfur-containing compound and (D) a chlorinated wax.
Patent IL-83661-A0 (IL)
Title: Dihydropyridine compounds,their preparation and pharmaceutical compositions containing them
IPC: C07D491/044
Filed: 1987-08-27
Abstract: Blood-sugar-lowering dihydropyridines of the formula   <IMAGE>   in which R1 represents phenyl, naphthyl, thienyl, pyridyl, chromenyl or thiochromenyl, it being possible for the radicals mentioned each to carry up to 2 identical or different substituents from the series comprising halogen, alkyl, alkoxy and alkylthio with in each case up to 6 carbon atoms, fluoroalkyl and fluoroalkoxy with in each case up to 3 carbon atoms and 3 fluorine atoms, nitro and cyano, R2 represents straight-chain, branched or cyclic alkyl which has up to 8 carbon atoms, can be interrupted in the alkyl chain by an oxygen or a sulphur atom and can be substituted by halogen, phenyl, cyano, hydroxyl, amino, alkylamino or dialkylamino with in each case up to 3 carbon atoms per alkyl group or by N-benzylmethylamino, R3 represents straight-chain, branched or cyclic alkyl which has up to 6 carbon atoms, can be interrupted in the alkyl chain by an oxygen atom and can be substituted by halogen, hydroxyl, amino, phenyl, morpholino, carboxy or alkoxycarbonyl with up to 4 carbon atoms and R4 and R5 each represent hydroxyl, or R4 and R5 together represent -O-, or a physiologically acceptable salt thereof.
Patent IL-86958-A0 (IL)
Title: Human monoclonal antibody igm 16-88,cell lines producing it and antigen recognized thereby
IPC: A61K39/395
Filed: 1988-07-03
Abstract: The present invention comprises the epitope recognized by the human monoclonal antibody 16-88, the human tumor antigen containing this epitope, which we have identified, isolated and characterized, and anti-idiotypic antibodies to human MCA 16-88, which comprise the same epitope. The invention also relates to the use of antibodies to the antigen containing this epitope for diagnosis and monitoring of treatment of cancer and to the use of this antigen in the preparation of vaccines to elicit an immune response similar to that obtained against tumor cells containing this epitope.
Patent IL-88731-A0 (IL)
Title: Non-reverting rna viruses
IPC: C12N7/00
Filed: 1988-12-20
Abstract: This invention relates to attenuated RNA viral strains having a low rate of replication. More particularly this invention relates to vaccines and the use of such vaccines comprising those attenuated RNA viral strains.
Patent IL-96314-A0 (IL)
Title: Spinning nozzle
IPC: D01D4/08
Filed: 1990-11-12
Abstract: In a spinneret, the spinning plate having the spinning capillaries (9) consists, according to the invention, of a carrier plate (2) having holes (7), especially stepped bores, into which are inserted or pressed small plates (8) containing the capillaries (9). The carrier plate (2) can therefore be of any thickness and consist of material of any strength, in order to achieve a high pressure resistance, without making it difficult to produce closely arranged capillaries (9), since the capillaries can be made in the softer small plates (8). <IMAGE>
Patent FI-20002154-A0 (FI)
Inventor: EEROLA VILLE
IPC: H04B1/707
Filed: 2000-09-29
Abstract: A device for detecting a demodulated signal received by a spread spectrum receiver and converted into digital samples. The device is characterized by a matched filter for calculating the correlation between an incoming signal and at least one reference signal, an oscillator for generating a sampling frequency, and a sampling circuit for re-sampling the demodulated digital sample signal at the sampling frequency, which is such that the timing of samples of the references signals of the matched filter corresponds to the timing of a sample signal going from the sampling circuit to the matched filter. The device also includes a multiplier in which the sample signal is multiplied by a carrier replica generated locally before the sampling circuit or thereafter, to remove the carrier from the sample signal.
Patent FI-20040037-A0 (FI)
Inventor: NIEMENMAA JARKO
IPC: H04L12/28
Filed: 2004-01-13
Abstract: In a method in association with a communication system a request for a connection is signaled between a user equipment and another party. The requested connection is then analyzed. Subsequent to detection that location information is required in association with the requested connection, a process for determining information about the location of the user equipment is activated. First information in association with the determining process is communicated on a control plane between the user equipment and the communication system, while second information in association with the determining process is communicated on a user plane between the user equipment and the communication system. An arrangement in association with location services and a user equipment capable of providing location information is also disclosed.
Patent FI-20050120-A0 (FI)
Inventor: KAERKKAEINEN VESA
IPC: E05F3/12
Filed: 2005-02-02
Abstract: The invention relates to a door closer, particularly to relief valve constructions for door closer fluid. A valve (1) according to the invention includes a gasket groove (3) fitted with a gasket (4), which is arranged to allow the door closer fluid to emerge from the door closer so that the gasket groove (3) allows the gasket (4) to protrude from the groove and/or break once the fluid pressure within the door closer reaches a certain level.
Patent IL-136759-A0 (IL)
Title: Thermoweldable clip for conduits
IPC: F16L47/03
Filed: 1998-12-14
Abstract: A thermoweldable clip for a weldable conduit has two shells surrounding the conduit when in use. The shells have facing longitudinal flanges and are connected to one another under pressure. The shells have electrically heatable conductors arranged in continuous windings at inner shell surfaces. The windings extend in a semi-circular zone at the inner surfaces in two end areas of the shell and also between these two semi-circular zones in a planar strip. The shape and the arrangement of the conductors are identical. The shells are positioned so as to face one another. The strip is arranged only at the inner surface of one of the longitudinal flanges. Electrical terminals are formed integrally on the outer shell sides. The conductors project from the contact surface of the semi-circular zones or the strip on the longitudinal flange. A positive locking connection is provided between the conductors and the shell material.
Patent IL-145017-A0 (IL)
Title: METHOD FOR PRODUCING 4,4-DIMETHYL-3β-HYDROXYPREGNA-8,14-DIENE-21 -CARBOXYLIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD
IPC: C07J1/00
Filed: 2000-03-16
Abstract: The invention relates to a method for representing compounds of the general formula (1). The invention further relates to the hitherto unknown compounds of general formulas (5, 6 and 7) in the form of intermediate products and to the use of 4,4-dimethyl-3beta hydroxypregna-8,14-diene-21-carboxylic acid esters of the general formula (1) for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol (2).
Patent IL-145542-A0 (IL)
Title: Method and preparation for the photochromic marking and/or for securing the authenticity of objects
IPC: C09K9/02
Filed: 2000-03-31
Abstract: Method and preparation for the photochromic labeling and/or for protecting the authenticity of objects, in which bacteriorhodopsin materials and preparations therefrom are used for application to the objects; preference is given to using a combination of low-level and high-level security features in said bacteriorhodopsin materials and preparations therefrom.
Patent IL-148091-A0 (IL)
Title: Methods and compositions for linear isothermal amplification of polynucleotide sequences
IPC: C12N15/09
Filed: 2000-09-13
Abstract: The present invention provides novel composite primers. The composite primers are suitable for use in isothermal, single primer linear nucleic acid amplification methods, such as methods for amplifying complementary DNA using the composite primer, primer extension, strand displacement, and optionally a termination sequence or methods for amplifying sense RNA using a composite primer, primer extension, strand displacement, optionally template switching, a propromoter olignucleotide and transcription. The invention further provides compositions and kits comprising the composite primers.
Patent IL-155281-A0 (IL)
Title: Methods for determining protein and peptide terminal sequences
IPC: G01N33/68
Filed: 2001-10-19
Abstract: Mass tagging methods are provided that lead to mass spectrometer detection sensitivities and molecular discriminations that are improved over other methods. In particular the methods are useful for discriminating tagged molecules and fragments of molecules from chemical noise in the mass spectrum. These mass tagging methods are useful for oligomer sequencing, determining the relative abundances of molecules from different samples, and identifying individual molecules or chemical processing steps in combinatorial chemical libraries. The methods provided are useful for the simultaneous analysis of multiple molecules and reaction mixtures by mass spectrometric methods.
Patent IL-160641-A0 (IL)
Title: Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
IPC: A01N53/06
Filed: 2002-09-19
Abstract: A pharmaceutical or agrochemical composition or kit of parts comprises (1) a micro-particle or micro-capsule comprising at least one pharmaceutical or agrochemical benefit agent and (2) a fusion protein which comprises a first binding domain which is a carbohydrate binding domain and at least one additional binding domain capable of binding to (a) a ligand or specific site which forms part of a living organism, or (b) said microcapsule or micro-particle, wherein the first or second binding domain is capable of binding to said microcapsule or microparticle. The fusion protein itself may also be used for therapeutic or agrochemical purposes.
Patent IL-161115-A0 (IL)
Title: Container uncapping apparatus and method
IPC: B01D63/08
Filed: 2002-10-21
Abstract: An automated system and method for individually processing multiple specimens of particulate matter-containing liquid in respective containers. The containers are transported seriatim along a processing path to present them to, at least, a preprocessing apparatus (e.g., a mixing head), and then to a specimen acquisition apparatus, which removes preprocessed specimen fluid from the container for subsequent analytical testing or evaluation. Each apparatus is actuated in response to presentation of a container thereto so as to carry out its respective operation independently. An exemplary system can include, in sequential order, stations for container loading and unloading, container uncapping and cap disposal, specimen mixing, filter loading, specimen acquisition (e.g., by aspiration, and then slide printing), filter disposal, and container resealing. The system is capable of unattended operation for many hours at a time, and can interface with an integrated data management system to provide fully integrated specimen and information management in a complete diagnostic laboratory system.
Patent IL-164719-A0 (IL)
Title: Apparatus, method and computer program to reserve resoutces in communications system
Filed: 2004-10-20
Abstract: A Resource Reservation System includes a Token Generation Unit (TGU) which generates and circulates among nodes of a communications system a Slotted Token (SLT) message having sub-fields to carry identification number for each input port in a node and the resource available for each input port. On receiving the message the Resource Control Unit (RCU) in each node can write port identification number, available resource in appropriate sub-fields of the SLT message, and reserve resources in other nodes by adjusting information in the sub-field associated with the other nodes.
Patent IL-179707-A0 (IL)
Title: System and method for controlling metamerism
IPC: G01J3/46
Filed: 2006-11-29
Abstract: The present invention provides a plurality of representations of color that are stored in an electronic color library and that can be selected by a user. After a color selection is made, a plurality of color ink formulas and/or colorant formulas capable of producing the selected color are provided. Further, other selections can be made to define a substrate or other criteria that can impact the color ink formulas. A plurality of color ink and/or colorant formulas are provided and optimized in order to reduce or eliminate undesired effects caused by metamerism. The formulas can be transmitted over a communication network, such as the Internet or a local Intranet to another party, such as color products manufacturers.
Patent IL-195996-A0 (IL)
Title: Caspase-8 and inflammation, infection and wound healing
IPC: C12N15/113
Filed: 2008-12-17
Abstract: The present invention relates to the regulatory role of caspase-8 in infection by intracellular pathogen, inflammation and wound healing
Patent MC-1424-A1 (MC)
Inventor: NORMAN GOEDDEL DAVID VAN
IPC: C12N15/00
Filed: 1981-11-09
Abstract: Microbially produced hybrid human leukocyte interferons, useful in the treatment of viral and neoplastic diseases, and means used in their production, i.e. recombinant DNA molecules coding for the amino acid sequences of these interferons, vectors capable of expressing these interferons in microbial host organisms and host organisms transformed with these vectors.
Patent ZM-2391-A1 (ZM)
Title: Polyester polymer products
IPC: B29C49/00
Filed: 1991-06-17
Abstract: Refillable polyethylene terephthalate (PET) bottles are made by injection stretch blow moulding and comprise a threaded neck of transparent amorphous substantially non-oriented PET; a substantially cylindrical body of transparent biaxially oriented amorphous PET from 0.4 to 0.9 mm thick and an area expansion ratio of at least 7; and a base of transparent amorphous substantially non-oriented or partly oriented PET in which the PET is a polyethylene terephthalate polymer randomly modified by replacing from 1 to 6 mole % of the terephthalate units with units of a chain orientation disrupting aromatic dicarboxylic acid, such as iso-phthalic acid, having an Intrinsic Viscosity of at least 0.75. The polymer particularly includes fine metal particles especially of antimony to reduce the reheat, and optionally includes a level of diethylene glycol residues greater than normally present in PET to improve the blowing performance of the polymer.
Patent IE-910938-A1 (IE)
Title: Process and intermediates for 2R-benzyl-chroman-6-carbaldehyde
Inventor: URBAN FRANK JOHN
IPC: C12R1/39
Filed: 1991-03-21
Abstract: Optically active (C1-C3)alkyl 2R-chroman-2-carboxylates are prepared by partial hydrolysis of the corresponding racemic ester using a microbial lipase as catalyst. Said 2R-chromancarboxylate is converted via novel 2R-(hydroxymethyl)chroman, 2R-(trifluoromethylsulfonyloxymethyl)chroman and 2R-benzylchroman intermediates into 2R-benzylchroman-6-carbaldehyde, a compound of known utility in the manufacture of certain hypoglycemic agents.
Patent MA-25272-A1 (MA)
Inventor: MARK HUNTLEY
IPC: A01G25/02
Filed: 2001-06-20
Abstract: An improved drip irrigation hose is provided. The hose has a water supply passage and a plurality of flow regulating channels manufactured into the hose that are smaller than the water supply passage. The flow regulating channels each comprise a predesignated geometry to provide a desired discharge rate at a given pressure, an inlet section comprising one or more openings connecting the water supply passage to that flow regulating channel, and an outlet section comprising one or more openings connecting that flow regulating channel to the exterior of the hose. The plurality of flow regulating channels have at least two different geometries to provide at least two different discharge rates at the given pressure. field. This invention has value to the irrigation designer in that it allows the designer to select emitter characteristics depending on the position of the emitter in the field.
Patent MA-26965-A1 (MA)
Title: Association d'agonistes de gaba et d'inhibiteurs d'aldose-reductase.
Inventor: MYLARI BANAVARA LAKSHMAN
IPC: A61P25/28
Filed: 2003-05-20
Abstract: DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US	30 Novembre 2000	60/250,448 Voir en annexe le titre de linvention et le texte de labrégé Association d'agonistes de GABA et d'inhibiteurs d'aldose-réductase L'invention concerne des compositions pharmaceutiques comprenant des associations d'un agoniste de GABA, d'un de ses précurseurs médicamenteux ou d'un sel pharmaceutiquement acceptable dudit agoniste de GABA ou dudit précurseur médicamenteux, et d'un ARI, d'un de ses précurseurs médicamenteux ou d'un sel pharmaceutiquement acceptable dudit ARI ou dudit précurseur médicamenteux, des kits contenant ces associations, et des méthodes d'utilisation de ces associations pour le traitement de mammifères, y compris l'homme, souffrant de complications diabétiques telles que la neuropathie diabétique, la néphropathie diabétique, la myocardiopathie diabétique, la rétinopathie diabétique, la microangiopathie diabétique, la macroangiopathie diabétique, les cataractes ou les ulcères des pieds.
Patent MA-27758-A1 (MA)
Title: Derives de phtalazinone
Inventor: MARTIN NIALL MORRISON BARR
IPC: C07D405/14
Filed: 2005-10-03
Abstract: L'invention concerne des composés de formule (I): dans laquelle A et B représentent ensemble un noyau aromatique éventuellement substitué et fusionné; X peut désigner NRX ou CRXRY; si X = NRX alors n prend la valeur de 1 ou 2 et si X = CRXRY alors n prend la valeur de 1; Rx est sélectionné dans le groupe comprenant H, C1-20 alkyle éventuellement substitué, C5-20 aryle, C3-20 hétérocyclyle, amido, thioamido, ester, acyle, et des groupes sulfonyle; RY est sélectionné parmi H, hydroxy, amino; ou Rx et RY peuvent former ensemble spiro-C3-7 cycloalkyle ou un groupe hétérocyclyle; RC1 et RC2 représentent tous deux l'hydrogène ou quand X désigne CRX RY, RC1, RC2, Rx et RY, conjointement avec les atomes de carbone auxquels ils sont fixés, ils peuvent former un noyau aromatique éventuellement substitué et fusionné; et R1 est sélectionné parmi H et halo.
Patent MA-39440-A1 (MA)
Title: Dispositif portable d'ultrafiltration
Inventor: ZAMD MOHAMED
IPC: A61M1/16
Filed: 2016-11-07
Abstract: L'invention concerne un dispositif portable pour ultrafiltration qui comporte un soufflet aspiratif relié par une tubulure passant à travers une électrovanne à l'un des embouts dialysat d'un hémofiltre intégré dans un circuit sanguin fait lui-même de lignes artérielles émanant d'un abord vasculaire et passant à travers une pompe péristaltique et de lignes veineuses passant à travers un bloc électronique de sécurité et rejoignant l'abord vasculaire alors que l'autre embout dialysat est relié à un détecteur de pression d'ultrafiltration. La pompe péristaltique, le bloc électronique de sécurité, le détecteur de pression d'ultrafiltration et i'électrovanne sont relié et contrôlés par une unité centrale intelligente alimenté par une batterie rechargeable. Le sang du patient circule dans le circuit sanguin et la pression négative générée par le soufflet aspiratif est transmise à travers la tubulure de raccordement et provoque l'ultrafiltration du sang à travers les fibres de l'hémofiltre. Ainsi du liquide s'accumule dans l'espace entourant les fibres et dans le soufflet aspiratifjusqu'à remplissage complet de celui-ci. Au fur et à mesure du remplissage du soufflet aspiratif la pression négative qu'il exerce s'atténue jusqu'à devenir nulle puis s'accroit lentement jusqu'à atteindre le niveau de la pression régnant dans le sang contenu dans les fibres. A ce moment-là, l'ultrafiltration s'arrête et l'unité centrale indique la fin du traitement à l'utilisateur par une alarme visuelle et sonore. Le sang est restitué au patient par l'infusion d'une solution physiologique isotonique. L'hémofiltre et le soufflet aspiratif sont alors retirés du dispositif.
Patent MA-45889-A1 (MA)
Title: Procédé de recyclage de matériaux renfermant du cobalt
Inventor: SUETENS THOMAS
IPC: C22B23/02
Filed: 2017-10-16
Abstract: La présente invention concerne la récupération de cobalt à partir de matériaux renfermant du cobalt, en particulier de batteries secondaires au lithium-ion renfermant du cobalt, de batteries usagées, ou de leurs rebuts. Le procédé porte sur la récupération de cobalt à partir de matériaux renfermant du cobalt, comprenant les étapes suivantes : la fourniture d’un convertisseur, le chargement de moules de laitier et d’un ou plusieurs éléments parmi de la matte de cuivre, de la matte de cuivre-nickel et de l'alliage impur dans le convertisseur, et l’injection d’un gaz oxydant de manière à faire fondre la charge dans des conditions d'oxydation, ce qui permet d'obtenir un bain fondu comprenant une phase métallique brute, et un laitier renfermant du cobalt, et de séparer le métal brut du laitier renfermant du cobalt, caractérisé en ce que les matériaux renfermant du cobalt sont chargés dans le convertisseur. Ce procédé est particulièrement approprié pour le recyclage de batteries secondaires au lithium-ion renfermant du cobalt. Le cobalt est concentré en une quantité limitée de scories de convertisseur, à partir desquelles il peut être récupéré de manière économique, conjointement avec d'autres éléments tels que du cuivre et/ou du nickel.
Patent MA-48430-A1 (MA)
Title: Procédé et dispositif de préparation de solutions de sel de leucoindigo exemptes d'aniline
Inventor: LUCIC ERWIN
IPC: D06P1/22
Filed: 2018-08-10
Abstract: L'invention concerne un procédé de préparation d'une solution aqueuse de leucoindigo exempte d'aniline ou exempte d'aniline et exempte de n-méthylaniline à partir d'une solution aqueuse de leucoindigo comprenant de l'aniline ou de l'aniline et de la n-méthylaniline, la concentration en aniline ou en aniline et en n-méthylaniline étant déterminée selon la norme iso 14362-1:2017(e), ledit leucoindigo se présentant sous la forme d'un sel de métal alcalin, le procédé comprenant au moins les étapes (a) à (c) consistant à : (a) utiliser un flux de liquide comprenant ladite solution aqueuse de leucoindigo comprenant ladite ou lesdites amines ; (b) utiliser un flux de purification ; (c) mettre en contact ledit flux de liquide avec ledit flux de purification.
Patent UY-26632-A1 (UY)
Title: Nuevos derivados de eritromicina, su procedimiento de preparación y su aplicación como medicamentos
Inventor: AGORIDAS CONSTANTIN
Filed: 2001-03-23
Abstract: Nuevos derivados de eritromicina útiles como medicamentos de fórmula (I) en la cual R representa un radial -(CH2)nAr, en la cual n representa el número 3, 4 o 5, y Ar representa un radial heterocíclico, que el portador eventual de uno o varios sustituyentes elegidos del grupo de los radicales (II), o R representa un radical (III) y z representa un átomo de hidrógeno o el resto de un ácido, así como sus sales de adicción con los ácidos. La invención comprende también un procedimiento para la preparación de dichos compuestos.